Literature DB >> 23684505

Atrial natriuretic peptide and cardiac troponin I concentrations in healthy Warmblood horses and in Warmblood horses with mitral regurgitation at rest and after exercise.

Dagmar S Trachsel1, Colin C Schwarzwald, Caroline Bitschnau, Beat Grenacher, Michael A Weishaupt.   

Abstract

OBJECTIVE: Atrial natriuretic peptide (ANP) and cardiac troponin I (cTnI) serve as biomarkers for increased cardiac pressure/volume loading and for myocardial stress or damage. The objective was to describe the time course of plasma ANP concentrations (CpANP) and plasma cTnI concentrations (CpcTnI) in horses with mitral regurgitation (MR) compared to healthy horses at rest and after exercise, and to describe the relationship of CpANP with cardiac dimensions and intracardiac pressures. ANIMALS: 15 healthy Warmblood horses and 7 Warmblood horses with MR.
METHODS: Cardiac dimensions at rest were measured using echocardiography. All horses underwent standardized treadmill exercise. Biomarker concentrations and intracardiac pressures were measured at rest and after exercise. Hypotheses were tested using statistical methods. The level of significance was P < 0.05.
RESULTS: Horses with MR showed increased left atrial (LA) and left ventricular (LV) dimensions but similar exercise capacity compared to healthy horses. Pulmonary capillary wedge pressures (PCWP) and CpANP increased with exercise. Horses with MR had higher PCWP and higher CpANP at rest and after exercise compared to healthy horses, with the maximum difference in CpANP reached 10 min after exercise. CpANP was significantly related to PCWP and - although inconsistently and only in healthy horses - to echocardiographic indices of LA and LV size and function. CpcTnI was low throughout the study in both groups.
CONCLUSIONS: CpANP is increased in horses with MR and is related to LA pressures and to left heart dimensions. MR is not necessarily associated with exercise intolerance and exercise-induced myocardial stress or damage.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684505     DOI: 10.1016/j.jvc.2012.12.003

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  6 in total

1.  24-Hour Kinetics of Cardiac Troponin-T Using a "High-Sensitivity" Assay in Thoroughbred Chuckwagon Racing Geldings after Race and Associated Clinical Sampling Guidelines.

Authors:  E Shields; I Seiden-Long; S Massie; R Leguillette
Journal:  J Vet Intern Med       Date:  2017-11-24       Impact factor: 3.333

2.  The use of heart rate variability analysis to detect arrhythmias in horses undergoing a standard treadmill exercise test.

Authors:  Ladina Frick; Colin C Schwarzwald; Katharyn J Mitchell
Journal:  J Vet Intern Med       Date:  2018-12-05       Impact factor: 3.333

3.  Evaluation of cardiac troponin I, atrial natriuretic peptide and some oxidative/antioxidative biomarkers in the serum and hemolysate of trained Arabian horses after exercise.

Authors:  R Pourmohammad; M Mohri; H A Seifi; K Sardari
Journal:  Iran J Vet Res       Date:  2020       Impact factor: 1.376

4.  Analytical validation and establishment of reference intervals for a 'high-sensitivity' cardiac troponin-T assay in horses.

Authors:  E Shields; I Seiden-Long; S Massie; S Passante; R Leguillette
Journal:  BMC Vet Res       Date:  2016-06-13       Impact factor: 2.741

5.  Echocardiographic Assessment of Left Atrial Size and Function in Warmblood Horses: Reference Intervals, Allometric Scaling, and Agreement of Different Echocardiographic Variables.

Authors:  I M Huesler; K J Mitchell; C C Schwarzwald
Journal:  J Vet Intern Med       Date:  2016-06-30       Impact factor: 3.333

6.  Echocardiographic assessment of left ventricular size and systolic function in Warmblood horses using linear measurements, area-based indices, and volume estimates: A retrospective database analysis.

Authors:  Djamila Berthoud; Colin C Schwarzwald
Journal:  J Vet Intern Med       Date:  2020-11-28       Impact factor: 3.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.